The Magic of mRNA Will Push Medical Advances for Everyone
mRNA is one of the first molecules of life. While identified six decades ago as the carrier of the blueprint for proteins in living cells, its pharmaceutical…
Browsing Tag
mRNA
Scientists develop 20-subtype mRNA flu vaccine to protect against future flu pandemics: Promising…
An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial…
New Technique for Imaging mRNA Molecules Allows Study of RNA Synthesis in Brains of Live Mice
Scientists have developed a new technique for imaging mRNA molecules in the brains of living mice. The research reveals new insights into how memories are…
Scientists Can Now Image mRNA Molecules in Brains of Live Mice: Details
Scientists have developed a new technique for imaging mRNA molecules in the brains of living mice. The research reveals new insights into how memories are…
For mRNA, Covid Vaccines Are Just the Beginning
One of mRNA’s strengths is its “remarkable agility,” as Hatchett puts it. Its only raw ingredients are the four amino acid bases that form the “letters” of…
Moderna data shows mRNA isn’t a quick fix for the flu vaccine
The first data from clinical trials of Moderna’s mRNA-based seasonal flu vaccine, released by the company Friday morning, were underwhelming — a finding…
Experimental mRNA HIV vaccine safe, shows promise in animals
An experimental HIV vaccine based on mRNA -- the same platform technology used in two highly effective COVID-19 vaccines -- shows promise in mice and…
SoftBank in investment talks with mRNA vaccine firm Abogen: Sources
Chinese mRNA vaccine developer Suzhou Abogen Biosciences is in talks with Japan's SoftBank and other investors to raise $300 million-$400 million, people…
Anti-vax app squares off with Google, Apple over misinformation
A new social app designed as a community for the unvaccinated is testing Google and Apple Inc.’s policies concerning the spread of…
Moderna has begun human trials for an mRNA vaccine that targets multiple influenza strains-Health…
The company intends to recruit 180 adults in the United States for the Phase 1/2 portion of the trial to evaluate the safety and…